Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSERT: Oral Steroids with Glatiramer Acetate in RRMS
NCT00203047Phase 4Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2005
- Primary completion
- May 2009
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of prednisone in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Jan 2005; status: terminated.
02
Drugs
prednisone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00203047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203047.